Solid Book-to-Bill Ratio
The book-to-bill ratio continued to be solid at 1.09 for the full year of '24-'25, implying a solid foundation for future sales growth.
Positive Product Launch Impact
Product launches, especially in Europe with Elekta Evo and Elekta ONE Planning, received positive feedback and contributed to growth.
Improved Adjusted Gross Margin
The adjusted gross margin improved to 37.8%, increasing by 30 basis points year-over-year, supported by price increases and improved product mix.
Record High Q4 Gross Margin
The adjusted gross margin for Q4 improved significantly to 40.3%, an increase of 370 basis points year-over-year, marking the best Q4 gross margin in 5 years.
Strong Operating Cash Flow
Operating cash flow after continuous investment improved by SEK 376 million to SEK 1.248 billion in Q4, driven by improved earnings.
Strong Performance in Europe
Sales in EMEA increased by 16% in constant exchange rates compared to last year, driven by strong performance in Europe, supported by new product launches.
Accelerated Innovations and Competitive Portfolio
Elekta's product portfolio has been enhanced with new launches, making it highly competitive with adaptive treatments across all product lines.